Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

2.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.0K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

1.0K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.0K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.1K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.1K
Dialysis01:27

Dialysis

1.6K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.6K
Dialysis01:15

Dialysis

1.9K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.9K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

975
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
975

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Circulating PEG-indoleamine 2,3-dioxygenase ameliorates diverse inflammatory diseases without toxicity or compromising immunocompetence.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A Multifunctional Magnetic Microvesicle for Enhanced Chemodynamic Therapy and Immune Activation against Bacterial Infections.

ACS applied materials & interfaces·2026
Same author

Metal-Induced "Line-Plane-Helix" Mononuclear Platinum(II) Complexes: Stereochemical Configuration Control, Aggregation-Induced Phosphorescence, and Chiroptical Properties.

Inorganic chemistry·2026
Same author

Hospital Volume and Outcomes After Elective Abdominal Aortic Aneurysm Repair: A Systematic Review and Dose-Response Meta-Analysis.

Annals of vascular surgery·2026
Same author

Increasing Technical Complexity of EVAR Conversion over Time Is Not Associated with Worse Outcomes at a High-Volume Aortic Treatment Center.

Annals of vascular surgery·2026
Same author

Is 5.5 cm Still the Optimal Size Threshold to Treat AAA in Men? A Contemporary Cost-Utility Analysis.

Annals of surgery·2026

関連する実験動画

Updated: Feb 19, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.1K

血液透析後のアクセス関連の手機能障害 アクセス 配置 アクセス

Kyoungrae Kim1, Trace Thome1, Lauren Stone1

  • 1Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.

Kidney international reports
|February 18, 2026
PubMed
まとめ

血液透析アクセスの手術は,慢性腎臓病 (CKD) または末期腎臓病 (ESKD) の患者に手機能不全を引き起こし,筋肉縮とアクセスの障害を増加させます. 早期の介入は,より良い結果を出すために不可欠です.

キーワード:
アクセス障害 アクセス障害慢性腎臓病 慢性腎臓病 慢性腎臓病 慢性腎臓病 慢性腎臓病 慢性腎臓病 慢性腎臓病末期性腎臓病は,末期的な腎臓病である.手の機能不全が原因です.ヘモダイアリスへのアクセス筋肉の縮 筋肉の縮

さらに関連する動画

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

2.5K
Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
07:30

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique

Published on: April 1, 2022

9.3K

関連する実験動画

Last Updated: Feb 19, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.1K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

2.5K
Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
07:30

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique

Published on: April 1, 2022

9.3K

科学分野:

  • ネフロロジーはネフロロジーを用います.
  • 血管外科 血管外科
  • 筋肉骨科の研究について

背景:

  • アクセス関連の手機能不全 (ARHD) は,慢性腎臓病 (CKD) または末期腎臓病 (ESKD) を患っている患者において,血液透析へのアクセス配置後に一般的です.
  • ARHDは臨床結果と生活の質に悪影響を及ぼしますが,その根本的なメカニズムとアクセスの成熟への影響は十分に理解されていません.

研究 の 目的:

  • ヘモダイアリスアクセス手術後のARHDのメカニズムを調査する.
  • 透析へのアクセスの成熟障害に対するARHDの影響を評価する.

主な方法:

  • 39人のCKD/ESKD患者を対象に,血液透析のアクセス手術を受けていた長期的研究.
  • 術前および6週間の術後の機能評価 (握り力,指圧,障害,手技,感覚).
  • ブラキオラディアリスの筋肉バイオプシ分析 (形態学,ミトコンドリア機能,トランスクリプトミクス) と6ヶ月のアクセス成熟のフォローアップ.

主要な成果:

  • 手術の6週間後,患者は握り力 (13.5%),指圧 (30.6mm Hg),および肢体の障害の増加が著しく減少しました.
  • 筋肉ヒストロジーは,握り力低下と相関するミオファイバー縮 (12%減少) を明らかにした.
  • ミトコンドリアの含有量が増加し,指の圧力と逆に相関する;トランスクリプトミクスは,ミオファイバーの発達遺伝子の変化を示した.
  • ARHDは,6ヶ月で無助成熟不全の ~20%高い発生率と関連していました.

結論:

  • 血液透析アクセスの手術は,筋縮と変異した遺伝子発現によって特徴づけられるCKD/ESKD患者のARHDにつながる.
  • ARHDは,透析へのアクセスの成熟不全の増加と関連しています.
  • 発見は,ARHDを予防し,外科的結果を改善するために,早期発見とターゲットを絞った介入の必要性を強調しています.